GLENMARK
Glenmark Pharmaceuticals Limited
Healthcare
Share price
₹2,648
Market cap
₹74,733 Cr
1Y return
▲ 41%
A global research-led pharmaceutical company, Glenmark operates across generics, specialty, and over-the-counter business segments with a presence in more than 80 countries worldwide. The company develops and manufactures pharmaceutical products serving patients across multiple therapeutic areas including oncology, dermatology, and respiratory care. Its distinctive strength lies in combining generic drug manufacturing capabilities with specialty pharmaceutical development and maintaining a robust international distribution network across developed and emerging markets.
Investors holding Glenmark Pharmaceuticals Limited
6.01%
2.04%
1.97%
1.28%
Recent moves 10
UTI Mutual FundExited
UTI Mutual Fund is no longer listed among the major shareholders of Glenmark Pharmaceuticals Limited, having either completely exited or trimmed its previous 1.15 percent stake to somewhere below the 1 percent reporting threshold.
Read more
Invesco Mutual FundDecreased
Invesco Mutual Fund decreased its stake in Glenmark Pharmaceuticals Limited from 2.20% to 1.97%, selling 6,44,659 shares.
Read more
HDFC Mutual FundDecreased
HDFC Mutual Fund reduced its stake in Glenmark Pharmaceuticals from 6.22% to 6.01%, selling 6,13,353 shares.
Read more
Government Pension Fund Global (Norway)Decreased
Government Pension Fund Global (Norway) reduced its stake in Glenmark Pharmaceuticals from 3.89% to 3.83%, selling 1,69,845 shares.
Read more
Amansa HoldingsDecreased
Amansa Holdings trimmed its stake in Glenmark Pharmaceuticals Limited from 2.22% to 2.04%, selling 4,80,904 shares.
Read more
Bandhan Mutual FundIncreased
Bandhan Mutual Fund increased its stake in Glenmark Pharmaceuticals from 1.17% to 1.28% by purchasing 2,94,675 shares.
Read more
Government Pension Fund Global (Norway)Increased
Government Pension Fund Global (Norway) increased its stake in Glenmark Pharmaceuticals Limited from 3.78% to 3.89%, raising its shareholding from 10,674,228 to 10,985,826 shares.
Read more
UTI Mutual FundDecreased
UTI Mutual Fund decreased its stake in Glenmark Pharmaceuticals from 1.27% to 1.15%, selling 3,19,539 shares.
Read more
Invesco Mutual FundIncreased
Invesco Mutual Fund increased its stake in Glenmark Pharmaceuticals from 1.88% to 2.20%, purchasing 903,000 shares.
Read more
HDFC Mutual FundIncreased
HDFC Mutual Fund raised its stake in Glenmark Pharmaceuticals from 6.11% to 6.22% by purchasing 3,31,659 shares.
Read more
Track the whales in Glenmark Pharmaceuticals Limited
Get alerted the moment a top investor buys or sells.
Start 7 days for ₹1